TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
2. Peptide Therapeutics Market - Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Peptide Therapeutics - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America - PEST Analysis
4.2.2 Europe - PEST Analysis
4.2.3 Asia Pacific - PEST Analysis
4.2.4 Middle East and Africa (MEA) - PEST Analysis
4.2.5 South and Central America (SCAM) - PEST Analysis
4.3 Expert Opinion
5. Peptide Therapeutics Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Growing Investments on Peptide Therapeutics
5.1.2 Increasing Prevalence of Metabolic Disorders and Infectious Diseases
5.2 Market Restraints
5.2.1 Operational Limitations of Peptides
5.3 Market Opportunities
5.3.1 Strong Pipeline and Applications of Peptide Drugs
5.4 Future Trends
5.4.1 Emphasis on Automatic Peptide Synthesis
5.5 Impact Analysis
6. Peptide Therapeutics Market - Global Analysis
6.1 Global Peptide Therapeutics Market Revenue Forecast And Analysis
6.2 Global Peptide Therapeutics Market, By Geography - Forecast And Analysis
6.3 Market Positioning of Key Players
7. Peptide Therapeutics Market Analysis - By Type
7.1 Overview
7.2 Peptide Therapeutics Market Revenue Share, by Type (2019 and 2027)
7.3 Generic
7.3.1 Overview
7.3.2 Generic: Peptide Therapeutics Market - Revenue and Forecast to 2027 (US$ Million)
7.4 Innovative
7.4.1 Overview
7.4.2 Innovative: Peptide Therapeutics Market - Revenue and Forecast to 2027 (US$ Million)
8. Peptide Therapeutics Market Analysis - By Route of Administration
8.1 Overview
8.2 Peptide Therapeutics Market Revenue Share, by Route of Administration (2019 and 2027)
8.3 Parenteral
8.3.1 Overview
8.3.2 Parenteral: Peptide Therapeutics Market - Revenue and Forecast to 2027 (US$ Million)
8.4 Oral
8.4.1 Overview
8.4.2 Oral: Peptide Therapeutics Market - Revenue and Forecast to 2027 (US$ Million)
8.5 Mucosal
8.5.1 Overview
8.5.2 Mucosal: Peptide Therapeutics Market - Revenue and Forecast to 2027 (US$ Million)
8.6 Pulmonary
8.6.1 Overview
8.6.2 Pulmonary: Peptide Therapeutics Market - Revenue and Forecast to 2027 (US$ Million)
8.7 Others
8.7.1 Overview
8.7.2 Others: Peptide Therapeutics Market - Revenue and Forecast to 2027 (US$ Million)
9. Peptide Therapeutics Market Analysis - By Synthesis Technology
9.1 Overview
9.2 Peptide Therapeutics Market Revenue Share, by Synthesis Technology (2019 and 2027)
9.3 Solid Phase Peptide Synthesis (SPPS)
9.3.1 Overview
9.3.2 Solid Phase Peptide Synthesis (SPPS): Peptide Therapeutics Market - Revenue and Forecast to 2027 (US$ Million)
9.4 Liquid Phase Peptide Synthesis (LPPS)
9.4.1 Overview
9.4.2 Liquid Phase Peptide Synthesis (LPPS): Peptide Therapeutics Market - Revenue and Forecast to 2027 (US$ Million)
9.5 Hybrid Technology
9.5.1 Overview
9.5.2 Hybrid Technology: Peptide Therapeutics Market - Revenue and Forecast to 2027 (US$ Million)
10. Peptide Therapeutics Market- Application
10.1 Overview
10.2 Peptide Therapeutics Market Share, Application, 2019 and 2027 (%)
10.3 Cancer
10.3.1 Overview
10.3.2 Cancer: Peptide Therapeutics Market Market- Revenue and Forecast to 2027 (US$ million)
10.4 Cardiovascular Disorders
10.4.1 Overview
10.4.2 Cardiovascular Disorders: Peptide Therapeutics Market Market- Revenue and Forecast to 2027 (US$ million)
10.5 Metabolic Disorder
10.5.1 Overview
10.5.2 Metabolic Disorder: Peptide Therapeutics Market Market- Revenue and Forecast to 2027 (US$ million)
10.6 Respiratory Disorders
10.6.1 Overview
10.6.2 Respiratory Disorders: Peptide Therapeutics Market Market- Revenue and Forecast to 2027 (US$ million)
10.7 Pain
10.7.1 Overview
10.7.2 Pain: Peptide Therapeutics Market Market- Revenue and Forecast to 2027 (US$ million)
10.8 Dermatology
10.8.1 Overview
10.8.2 Dermatology: Peptide Therapeutics Market Market- Revenue and Forecast to 2027 (US$ million)
11. Peptide Therapeutics Market - Australia Analysis
11.1 Australia: Peptide Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
11.1.1 Australia: Peptide Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
11.1.2 Australia: Peptide Therapeutics Market, by Type, 2018-2027 (USD Million)
11.1.3 Australia: Peptide Therapeutics Market, by Route of Administration, 2018-2027 (USD Million)
11.1.4 Australia: Peptide Therapeutics Market, by Synthesis Technology, 2018-2027 (USD Million)
11.1.5 Australia: Peptide Therapeutics Market, by Application, 2018-2027 (USD Million)
12. Impact of COVID-19 Pandemic on Global Peptide Therapeutics Market
12.1 North America: Impact Assessment of COVID-19 Pandemic
12.2 Europe: Impact Assessment of COVID-19 Pandemic
12.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
12.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
12.5 South and Central America: Impact Assessment of COVID-19 Pandemic
13. Peptide Therapeutics Market- Industry Landscape
13.1 Overview
13.1 Growth Strategies Done by the Companies in the Market, (%)
13.2 Organic Developments
13.2.1 Overview
13.3 Inorganic Developments
13.3.1 Overview
14. Company Profiles
14.1 Amgen Inc.
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Eli Lilly and Company
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 EVER Pharma GmbH
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Polypeptide Group
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 TEVA PHARMACEUTICAL INDUSTRIES LTD
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 AstraZeneca
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 Bristol-Myers Squibb Company
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 GlaxoSmithKline plc.
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 Novo Nordisk A/S
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 Sanofi
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
15. Appendix
15.1 About The Insight Partners
15.2 Glossary of Terms


LIST OF TABLES
Table 1. Australia Peptide Therapeutics Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 2. Australia Peptide Therapeutics Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 3. Australia Peptide Therapeutics Market, by Synthesis Technology - Revenue and Forecast to 2027 (USD Million)
Table 4. Australia Peptide Therapeutics Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 5. Organic Developments Done by Companies
Table 6. Inorganic Developments Done by Companies
Table 7. Glossary of Terms, Peptide Therapeutics Market


LIST OF FIGURES
Figure 1. Global Peptide Therapeutics Market Overview
Figure 2. Innovative Segment Held Largest Share of Peptide Therapeutics Market
Figure 3. APAC to Show Significant Growth During Forecast Period
Figure 4. Peptide Therapeutics Market, by Geography (US$ Million)
Figure 5. Global Peptide Therapeutics Market - Leading Country Markets (US$ Million)
Figure 6. Global Peptide Therapeutics Market, Industry Landscape
Figure 7. North America PEST Analysis
Figure 8. Europe PEST Analysis
Figure 9. Asia Pacific PEST Analysis
Figure 10. Middle East & Africa PEST Analysis
Figure 11. South and Central America (SCAM) PEST Analysis
Figure 12. Peptide Therapeutics Market Impact Analysis of Drivers and Restraints
Figure 13. Global Peptide Therapeutics Market - Revenue Forecast and Analysis - 2019- 2027
Figure 14. Global Peptide Therapeutics Market - By Geography Forecast and Analysis - 2019- 2027
Figure 15. Market Positioning of Key Players in Global Peptide Therapeutics Market
Figure 16. Peptide Therapeutics Market Revenue Share, by Type (2019 and 2027)
Figure 17. Generic: Peptide Therapeutics Market - Revenue and Forecast to 2027 (US$ Million)
Figure 18. Innovative: Peptide Therapeutics Market - Revenue and Forecast to 2027 (US$ Million)
Figure 19. Peptide Therapeutics Market Revenue Share, by Route of Administration (2019 and 2027)
Figure 20. Parenteral: Peptide Therapeutics Market - Revenue and Forecast to 2027 (US$ Million)
Figure 21. Oral: Peptide Therapeutics Market - Revenue and Forecast to 2027 (US$ Million)
Figure 22. Mucosal: Peptide Therapeutics Market - Revenue and Forecast to 2027 (US$ Million)
Figure 23. Pulmonary: Peptide Therapeutics Market - Revenue and Forecast to 2027 (US$ Million)
Figure 24. Others: Peptide Therapeutics Market - Revenue and Forecast to 2027 (US$ Million)
Figure 25. Peptide Therapeutics Market Revenue Share, by Synthesis Technology (2019 and 2027)
Figure 26. Solid Phase Peptide Synthesis (SPPS): Peptide Therapeutics Market - Revenue and Forecast to 2027 (US$ Million)
Figure 27. Liquid Phase Peptide Synthesis (LPPS): Peptide Therapeutics Market - Revenue and Forecast to 2027 (US$ Million)
Figure 28. Hybrid Technology: Peptide Therapeutics Market - Revenue and Forecast to 2027 (US$ Million)
Figure 29. Peptide Therapeutics Market Share, Application, 2019 and 2027 (%)
Figure 30. Cancer: Peptide Therapeutics Market Market- Revenue and Forecast to 2027 (US$ million)
Figure 31. Cardiovascular Disorders: Peptide Therapeutics Market Market- Revenue and Forecast to 2027 (US$ million)
Figure 32. Metabolic Disorder: Peptide Therapeutics Market Market- Revenue and Forecast to 2027 (US$ million)
Figure 33. Respiratory Disorders: Peptide Therapeutics Market Market- Revenue and Forecast to 2027 (US$ million)
Figure 34. Pain: Peptide Therapeutics Market Market- Revenue and Forecast to 2027 (US$ million)
Figure 35. Dermatology: Peptide Therapeutics Market Market- Revenue and Forecast to 2027 (US$ million)
Figure 36. Australia: Peptide Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
Figure 37. Impact of COVID-19 Pandemic in North America Country Markets
Figure 38. Impact of COVID-19 Pandemic in European Country Markets
Figure 39. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
Figure 40. Impact of COVID-19 Pandemic in Middle East and Africa Market
Figure 41. Impact of COVID-19 Pandemic in South and Central America Market
Figure 42. Growth Strategies Done by the Companies in the Market, (%)